{"public_id":"co_fe2c70021bf11fafc7c733a280e61f54","status":"active","merged_into_public_id":null,"resolved_public_id":"co_fe2c70021bf11fafc7c733a280e61f54","name":"polysaccharopeptide","description":"A polysaccharide-peptide compound derived from Coriolus versicolor and used here as a pre-treatment agent.","aliases":["PSP","Coriolus versicolor polysaccharopeptide","Yunzhi"],"types":["compound","treatment agent"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":261937059,"title":"Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells","citation_count":21,"url":"https://sah.borca.ai/papers/261937059"}],"claims":[{"public_id":"cl_197017b2409ceb3a38a1ff8cd4ceb719","text":"Polysaccharopeptide pre-treatment reduces HL-60 cell proliferation, inhibits progression through S and G2 phases, decreases 3H-thymidine uptake, and prolongs DNA synthesis time.","corpus_id":261937059,"url":"https://sah.borca.ai/claims/cl_197017b2409ceb3a38a1ff8cd4ceb719"},{"public_id":"cl_cd67bdd98bc4713f85c2cbf74073bf9b","text":"Polysaccharopeptide increases HL-60 cell sensitization to effective apoptotic cell death induced by camptothecin and acts as a potential adjuvant for leukemia treatment.","corpus_id":261937059,"url":"https://sah.borca.ai/claims/cl_cd67bdd98bc4713f85c2cbf74073bf9b"},{"public_id":"cl_e73eb495d665f345424503c1a5d22554","text":"Polysaccharopeptide pre-treated HL-60 cells show enhanced cytotoxicity to camptothecin.","corpus_id":261937059,"url":"https://sah.borca.ai/claims/cl_e73eb495d665f345424503c1a5d22554"},{"public_id":"cl_ea802b87ef838fabb9a526b481f07349","text":"Polysaccharopeptide and camptothecin do not induce detectable cell death in normal human peripheral blood mononuclear cells.","corpus_id":261937059,"url":"https://sah.borca.ai/claims/cl_ea802b87ef838fabb9a526b481f07349"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_fe2c70021bf11fafc7c733a280e61f54","url":"https://sah.borca.ai/concepts/co_fe2c70021bf11fafc7c733a280e61f54"}